Activity Preview

Live

PIP: Clinical Module for the Care of Adults with Schizophrenia

Activity Type:

  • Performance in Practice (PIP)


Release Date: 6/1/2012

Expiration Date: 3/13/2018

  • AAPA Performance Improvement: 20
  • AMA PRA Category 1 Physician: 20
  • Participation: 20

Access Activity

Overview

American Psychiatric Association Performance in Practice (PIP) Clinical Module for the Care of Adults with Schizophrenia Completion of stages A,B,C in sequence is designated by American Psychiatric Association for up to 20 AMA PRA Category 1 Credits™.

Pricing

  • General Member - Free
  • Resident-Fellow Member - Free
  • Non-Member - $399.00

Educational Objectives

By completing the Clinical Module for the Care of Adults with Schizophrenia, physicians will: · assess whether their current assessment and treatment is consistent with evidence-based recommendations; · identify areas of improvement and develop an improvement plan; and · improve the care of patients with a diagnosis of schizophrenia in clinical practice.

Target Audience

Psychiatrists participating in MOC and other psychiatrists in clinical practice; psychiatric residents and fellows; physicians who wish to improve their knowledge of clinical psychiatry and patient care; physician assistants participating in MOC.

Estimated Time to Complete

ESTIMATED TIME TO COMPLETE: 20 hours
Begin Date June 2012
Review Date June 2015
End Date March 13, 2018

How to Earn Credit

The APA's PIP modules are guided practice improvement programs created for psychiatrists, and are designed to meet Part 4 MOC requirements for clinical modules. Modules follow a three-stage Performance Improvement CME structure that takes place within a 24-month period. ABPN Maintenance of Certification requirements: http://www.abpn.com/moc.html

In STAGE A - Chart Review, the physician compares his or her current practice (through a review of chart documentation) to guidelines and measures provided for the topic area. No patient/chart data is submitted. (5 credits)

In STAGE B – Improvement, based upon the results of chart review, the physician then selects an area where improvement is needed and documents his or her strategy for improvement. This improvement plan is for the personal use of the physician, and is not submitted to the APA. Educational resources are suggested that can assist with the improvement plan, however, any educational activities relevant to the improvement plan can be used. During Stage B, the physician implements the educational plan for a period of 30 days or as long as the doctor deems necessary within 24 months. (5 credits)

In STAGE C – Second Chart Review, the physician reassesses his or her performance with review of 5 patient charts, and determines the results of his or her performance improvement effort. These can be the same 5 patients or a new group of patients seen since beginning the PIP activities. Again, the physician retains all patient/chart data. (10 credits) The complete module, three stages in sequence within 24 months, earns the participant a total of 20 CME credits.

Accreditation and MOC Approval

The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Psychiatric Association designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed the Clinical Module for the Care of Adults with Schizophrenia and has approved this program as a Performance in Practice Clinical Module (MOC Part 4) which is mandated by the ABMS as a necessary component of Maintenance of Certification.

APA reports MOC completion data on behalf of our members directly to ABPN, however, diplomates are still required to log on to their ABPN Physician Folios at least once per calendar year to attest to completion of their MOC activities.”  

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. Total number of approved credits for each stage of this PI-CME program are as follows: Stage A : 5.0 AAPA Category 1 PI-CME credits Stage B : 5.0 AAPA Category 1 PI-CME credits Stage C : 5.0 AAPA Category 1 PI-CME credits Bonus for completion of all three stages: 5.0 AAPA Category 1 PI-CME credits Approval is valid until June 30, 2018. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards. PIP forms are not submitted to APA or to ABPN. After completing each stage, continue to the evaluation to document your participation and enroll in the next stage. After all three stages are complete, you will have the opportunity to claim a certificate for up to 20 AMA PRA Category 1 Credits™.

Faculty and Planner Disclosures

Program Planners

  • Deborah J. Hales M.D., Director, American Psychiatric Association Division of Education, Arlington VA. Reports no financial relationships with commercial interests.
  • Mark Hyman Rapaport, M.D., Chairman, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, and Chief of Psychiatric Services, Emory Healthcare System, Atlanta GA . Disclosure: Consultant: PAX Neuroscience

Authors

  • Farifteh F. Duffy, PhD; American Psychiatric Foundation, American Psychiatric Institute for Research and Education, Arlington, VA. Reports no financial relationships with commercial interests.
  • Joyce C. West, PhD, MPP; American Psychiatric Foundation, American Psychiatric Institute for Research and Education, Arlington, VA. Reports no financial relationships with commercial interests.
  • Laura J. Fochtmann, MD; Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY. Reports no financial relationships with commercial interests.
  • Lisa Dixon, MD, MPH; University of Maryland School of Medicine, Baltimore, MD. Reports no financial relationships with commercial interests but reports the following (family member) Consultant/Advisor: Eli Lilly, Takeda, Hoffman-LaRoche, Bristol Myers Squibb, Abbott, Genentech, Endo Pharmaceuticals. DSMB: Otkuka. Research Funding: Pfizer, Novartis, Janssen, Pamlab, GlaxoSmith Kline
  • Julie Kreyenbuhl, Pharm D, PhD; VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC) and University of Maryland School of Medicine, Department of Psychiatry, Division of Services Research, Baltimore, MD. Reports no financial relationships with commercial interests.
  • Eve K. Moscicki, ScD, MPH; American Psychiatric Foundation, American Psychiatric Institute for Research and Education Robert Plovnick, MD, MS; American Psychiatric Association, Arlington, VA. Reports no financial relationships with commercial interests.
  • Robert Kunkle, MA, American Psychiatric Association, Arlington, VA. Reports no financial relationships with commercial interests.

Hardware/Software Requirements

  • For PC users, we recommend using a computer that is running the most recent version of Microsoft Windows.
  • For Macintosh users, we recommend using a computer that is running OS X or later.

Although the presentations and website can be viewed on any browser, we suggest Google Chrome for PC users and the latest version of Firefox for Macintosh users. Make sure your computer's software and browsers are updated regularly for an optimal experience.

Due to the media-rich content, we recommend viewing programs at a minimum screen resolution of 800 x 600 pixels, but preferably 1024 x 768 pixels.

Contact educme@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

All materials copyright American Psychiatric Association ©2012
American Psychiatric Association
Department of CME
1000 Wilson Blvd, Suite 1825
Arlington VA, 22209

Access Activity